Xin Liu

5PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 11, 2026
Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression.

|Apr 17, 2025
Advancements in Diagnostics and Therapeutics for Cancer of Unknown Primary in the Era of Precision Medicine.

Ting Zhao, Xiaowei Zhang, Xin Liu

|Nov 13, 2023
Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial.

Xiaomin Ou, Ruiping Zhai, Wenjun Wei

|Oct 14, 2022
Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study.

Xin Liu, Shiyu Jiang, Huijie Wang

Pageof 1

Frequent Collaborators

3 joint publications

Zhiguo Luo

3 joint publications

Xiaowei Zhang

2 joint publications

Dongmei Ji

2 joint publications

Chaosu Hu